PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.

@article{Lacey2008PTENEI,
  title={PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.},
  author={James V Lacey and George L. Mutter and Brigitte M. Ronnett and Olga B. Ioffe and M{\'a}ire A. Duggan and Brenda B. Rush and Andrew Glass and Douglas A. Richesson and Nilanjan Chatterjee and Bryan Langholz and Mark E. Sherman},
  journal={Cancer research},
  year={2008},
  volume={68 14},
  pages={6014-20}
}
Inactivation of PTEN tumor suppressor gene is common in endometrial carcinoma and its precursor, atypical endometrial hyperplasia (EH). We compared PTEN expression via immunohistochemistry in endometrial biopsies diagnosed as EH in 138 cases, who were diagnosed with EH and then endometrial carcinoma at least 1 year later (median, 6 years), and 241 individually matched controls, who were diagnosed with EH but did not progress to carcinoma during equivalent follow-up. We assessed PTEN status… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Emerging Therapeutic Biomarkers in Endometrial Cancer

BioMed research international • 2013
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Use of cohort information in the design and analysis of case-control studies

B. Langholz
Scand J Stat • 2007
View 1 Excerpt

Building a research consortium of large health systems: the Cancer Research Network.

Journal of the National Cancer Institute. Monographs • 2005
View 1 Excerpt

Endometrial hyperplasia/adenocarcinoma. a conventional approach.

Annals of diagnostic pathology • 2005
View 2 Excerpts

Endometrial hyperplasia: a review.

Obstetrical & gynecological survey • 2004
View 1 Excerpt

Similar Papers

Loading similar papers…